Skip to main content
. 2023 Mar 1;7(13):3049–3057. doi: 10.1182/bloodadvances.2022009230

Table 3.

Median (IQR) infusion interval (days) during the first 5 years (subanalysis 1)

Treatment regimen Start of the parent study End of follow-up Change (end to start)
Subjects from B-LONG
 WP n = 21 n = 21 n = 21
7.0 (7.0-7.0) 7.0 (7.0-7.0) 0.0 (0.0-0.0)
 Individualized IP n = 17 n = 17 n = 17
10.0 (10.0-10.0)
14.0 (10.0-14.0)
4.0 (0.0-4.0)
Subjects from Kids B-LONG
 WP n = 10 n = 10 n = 10
7.0 (7.0-7.0) 7.0 (7.0-7.0) 0.0 (0.0-0.0)